Vanquish Oncology, Inc. — Form D
Vanquish Oncology, Inc. of CHAMPAIGN, IL, a company, filed a Form D exempt-offering notice with the SEC on 2020-07-01. The offering totals $3.0M, of which $500K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-07-01
- Form: D
- Accession: 0001572746-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $500K
- Remaining: $2.5M
- Minimum investment: $50K
- Investors: 1
- Date of first sale: 2020-06-30
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-370122
Issuer
- Name: Vanquish Oncology, Inc.
- CIK: 0001572746
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 2001 S. FIRST ST., CHAMPAIGN, IL, 61820
- Phone: 510-219-6200
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Billie Jo Herberger | Director | Champaign, IL |
| Judd Herberger | Director | Champaign, IL |
| Paul Hergenrother | Director | Champaign, IL |
| Ted Tarasow | Director | Champaign, IL |
| Ted Tarasow | Executive Officer | Champaign, IL |
| Paul Hergenrother | Executive Officer | Champaign, IL |
| Ron Way | Director | Champaign, IL |
| Judd Heberger | Director | Champaign, IL |
Other filings by this issuer (4)
More